Skip to search formSkip to main contentSkip to account menu

troxerutin

Known as: 2-(3,4-bis(2-hydroxyethoxy)phenyl)-3-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-5-hydroxy-7-(2-hydroxy ethoxy)-4H-1-benzopyran-4-one, vitamin P4, 3',4',7-trihydroxyethylrutin 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Objectives Chronic venous insufficiency (CVI) is an important cause of discomfort and inability to work. Hydroxyethylrutosides… 
2005
2005
Summary The vascular changes associated with early diabetic retinopathy, which include the formation of microaneurysms and… 
Highly Cited
2002
Highly Cited
2002
The aim of this study was to confirm the clinical efficacy of oxerutins by evaluation of venous parietal tone and microvascular… 
2002
2002
The aim of this study was to demonstrate whether HR (Paroven-Venoruton; 0-(β-hydroxyethyl)-rutosides), was effective in improving… 
Review
1999
Review
1999
AbstractObjective: To evaluate, by means of a review of published data, the therapeutic effectiveness of drugs administered… 
1996
1996
The aim of this study was to investigate, if the the combined treatment of compression stockings and drug treatment with… 
1989
1989
The effect of Venoruton on the symptoms and microcirculation was investigated in an open randomised placebo controlled study… 
1987
1987
During ischemic perfusion and reperfusion of isolated rat hearts, OH and carbon-centered radicals were trapped in the perfusate…